Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Sponsor

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Germany Langenbeckstrasse 1, Oberstadt, 55131 Mainz, Germany

About the sponsor

Clinical research at Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz includes treatment strategies for small cell lung cancer, non-small cell lung cancer with EGFR alterations, and advanced neuroendocrine neoplasias G3.

  • Immunotherapy in lung cancer
  • Targeted therapy for EGFR-mutated disease
  • Advanced neuroendocrine tumor management

The sponsor’s trial portfolio in this area also covers combinations of systemic and local treatments for disease control and progression management.

About Specializations

Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR runs clinical trials in conditions such as Rectal cancer stage III, Rectal cancer stage II, Osteoarthritis, Mantle cell lymphoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

7 clinical trials

Rectal cancer stage III+1

Recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tislelizumab
  • Sponsor:Rabin Medical Center

Osteoarthritis

Recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Rivaroxaban
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Mantle cell lymphoma

Recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bendamustine
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

B-cell lymphoma refractory

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Oxaliplatin
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Small cell lung cancer limited stage

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Non-small cell lung cancer

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Afatinib
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Neuroendocrine carcinoma

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.